QDVX:XETRA:XETRA-iShares MSCI Europe Quality Dividend ESG UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 6.079

Change

-0.02 (-0.39)%

Market Cap

USD 0.64B

Volume

0.18M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-14 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.13 (+0.25%)

USD 426.26B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.05 (+0.28%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.01 (-0.04%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.04 (+0.12%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.01 (+0.04%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

-0.13 (-0.29%)

USD 104.42B
8R80:XETRA Amundi Index Solutions - Amund..

+0.30 (+0.21%)

USD 104.42B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.14 (+0.27%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

-0.10 (-0.10%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-1.58 (-0.26%)

USD 80.38B

ETFs Containing QDVX:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.94% 47% F 51% F
Dividend Return 3.34% 76% C+ 66% D+
Total Return 11.28% 56% F 58% F
Trailing 12 Months  
Capital Gain 14.59% 51% F 54% F
Dividend Return 3.55% 73% C 64% D
Total Return 18.14% 61% D- 61% D-
Trailing 5 Years  
Capital Gain 18.57% 45% F 50% F
Dividend Return 19.34% 91% A- 80% B-
Total Return 37.91% 58% F 60% D-
Average Annual (5 Year Horizon)  
Capital Gain 8.21% 61% D- 60% D-
Dividend Return 9.08% 64% D 62% D
Total Return 0.86% 60% D- 41% F
Risk Return Profile  
Volatility (Standard Deviation) 10.00% 62% D 70% C-
Risk Adjusted Return 90.79% 87% B+ 88% B+
Market Capitalization 0.64B 70% C- 62% D

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike